Invivyd (IVVD) Stock Forecast, Price Target & Predictions
IVVD Stock Forecast
Invivyd stock forecast is as follows: an average price target of $9.50 (represents a 748.21% upside from IVVD’s last price of $1.12) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
IVVD Price Target
The average price target for Invivyd (IVVD) is $9.50 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $10.00 to $9.00. This represents a potential 748.21% upside from IVVD's last price of $1.12.
IVVD Analyst Ratings
According to 4 Wall Street analysts, Invivyd's rating consensus is 'Buy'. The analyst rating breakdown for IVVD stock is 0 'Strong Buy' (0.00%), 4 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Invivyd Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Apr 05, 2024 | Evan Wang | Guggenheim | $9.00 | $3.58 | 151.40% | 703.57% |
| Mar 26, 2024 | Maxwell Skor | Morgan Stanley | $10.00 | $3.23 | 209.60% | 792.86% |
The latest Invivyd stock forecast, released on Apr 05, 2024 by Evan Wang from Guggenheim, set a price target of $9.00, which represents a 151.40% increase from the stock price at the time of the forecast ($3.58), and a 703.57% increase from IVVD last price ($1.12).
Invivyd Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $9.50 |
| Last Closing Price | $1.12 | $1.12 | $1.12 |
| Upside/Downside | -100.00% | -100.00% | 748.21% |
In the current month, the average price target of Invivyd stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Invivyd's last price of $1.12. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 28, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Apr 05, 2024 | Guggenheim | - | Buy | Upgrade |
| Mar 26, 2024 | Morgan Stanley | - | Overweight | Upgrade |
| Dec 16, 2021 | Jefferies | Buy | Buy | Hold |
Invivyd's last stock rating was published by H.C. Wainwright on Aug 28, 2024. The company gave IVVD a "Buy" rating, the same as its previous rate.
Invivyd Financial Forecast
Invivyd Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $117.00M | $58.50M | $38.50M | $72.00M | $120.10M | $33.23M | $5.00M | - | - | - |
| High Forecast | $140.84M | $70.42M | $46.34M | $86.67M | $144.57M | $37.07M | $6.02M | - | - | - |
| Low Forecast | $88.02M | $44.01M | $28.96M | $54.17M | $90.36M | $26.71M | $3.76M | - | - | - |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 2 | 3 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - |
Invivyd's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. IVVD's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Invivyd EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 2 | 3 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | $-43.06M |
| Avg Forecast | - | - | - | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - | - | - | - |
undefined analysts predict IVVD's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Invivyd's previous annual EBITDA (undefined) of $NaN.
Invivyd Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 2 | 3 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | $-39.44M |
| Avg Forecast | $17.31M | $-7.16M | $-26.26M | $-19.10M | $18.30M | $-39.79M | $-44.56M | $-53.96M | $-47.79M | $-55.43M |
| High Forecast | $21.89M | $-4.86M | $-17.81M | $-12.95M | $23.15M | $-31.35M | $-30.21M | $-53.96M | $-43.12M | $-47.36M |
| Low Forecast | $11.74M | $-9.06M | $-33.22M | $-24.16M | $12.41M | $-47.02M | $-56.36M | $-53.96M | $-54.78M | $-59.46M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.71% |
Invivyd's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. IVVD's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Invivyd SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 2 | 3 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | $12.89M |
| Avg Forecast | - | - | - | - | - | - | - | - | - | - |
| High Forecast | - | - | - | - | - | - | - | - | - | - |
| Low Forecast | - | - | - | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - | - | - | - |
Invivyd's average Quarter SG&A projection for Dec 23 is -, based on 3 Wall Street analysts, with a range of - to -. The forecast indicates a -100.00% fall compared to IVVD last annual SG&A of $12.89M (Sep 23).
Invivyd EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 2 | 3 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | $-0.00 |
| Avg Forecast | $0.14 | $-0.06 | $-0.22 | $-0.16 | $0.15 | $-0.33 | $-0.37 | $-0.47 | $-0.43 | $-0.51 |
| High Forecast | $0.18 | $-0.04 | $-0.15 | $-0.11 | $0.19 | $-0.26 | $-0.25 | $-0.47 | $-0.39 | $-0.43 |
| Low Forecast | $0.10 | $-0.08 | $-0.28 | $-0.20 | $0.10 | $-0.39 | $-0.47 | $-0.47 | $-0.50 | $-0.54 |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.00% |
According to undefined Wall Street analysts, Invivyd's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to IVVD previous annual EPS of $NaN (undefined).
Invivyd Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| UBX | Unity Bio | $1.42 | $80.00 | 5533.80% | Buy |
| IVVD | Invivyd | $1.11 | $9.50 | 755.86% | Buy |
| PASG | Passage Bio | $0.73 | $6.00 | 721.92% | Buy |
| KRON | Kronos Bio | $0.94 | $7.63 | 711.70% | Buy |
| BDTX | Black Diamond Therapeutics | $4.83 | $14.75 | 205.38% | Buy |
| RGNX | REGENXBIO | $12.95 | $38.00 | 193.44% | Buy |
| EWTX | Edgewise Therapeutics | $18.08 | $48.00 | 165.49% | Buy |
| ANEB | Anebulo Pharmaceuticals | $2.27 | $6.00 | 164.32% | Buy |
| ERAS | Erasca | $2.89 | $7.00 | 142.21% | Buy |
| CCCC | C4 Therapeutics | $6.46 | $11.33 | 75.39% | Hold |
| AVIR | Atea Pharmaceuticals | $4.02 | $6.88 | 71.14% | Hold |
| RXRX | Recursion Pharmaceuticals | $6.76 | $9.67 | 43.05% | Hold |
| ABEO | Abeona Therapeutics | $5.46 | $6.00 | 9.89% | Buy |
| EXAI | Exscientia | $5.03 | $5.00 | -0.60% | Hold |
IVVD Forecast FAQ
Is Invivyd a good buy?
Yes, according to 4 Wall Street analysts, Invivyd (IVVD) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 100.00% of IVVD's total ratings.
What is IVVD's price target?
Invivyd (IVVD) average price target is $9.5 with a range of $9 to $10, implying a 748.21% from its last price of $1.12. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Invivyd stock go up soon?
According to Wall Street analysts' prediction for IVVD stock, the company can go up by 748.21% (from the last price of $1.12 to the average price target of $9.5), up by 792.86% based on the highest stock price target, and up by 703.57% based on the lowest stock price target.
Can Invivyd stock reach $2?
IVVD's average twelve months analyst stock price target of $9.5 supports the claim that Invivyd can reach $2 in the near future.
What are Invivyd's analysts' financial forecasts?
Invivyd's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $158.33M (high $187.66M, low $120.82M), average EBITDA is $0 (high $0, low $0), average net income is $-120M (high $-92.368M, low $-145M), average SG&A $0 (high $0, low $0), and average EPS is $-1.02 (high $-0.788, low $-1.229). IVVD's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $286M (high $344.27M, low $215.17M), average EBITDA is $0 (high $0, low $0), average net income is $-35.212M (high $-13.72M, low $-54.695M), average SG&A $0 (high $0, low $0), and average EPS is $-0.295 (high $-0.115, low $-0.458).